2 completed, 2 recruiting, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Recruiting 2, Withdrawn 1 |
Follow Mucocutaneous Lymph Node Syndrome: new trials by email Literature Review of Mucocutaneous Lymph Node Syndrome trials Research Report on Mucocutaneous Lymph Node Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non Inferiority KawasakI Trial With Anakinra Anakinra, Intravenous Immunoglobulins, Human - Kawasaki Disease, Anakinra | Phase 4 | Withdrawn | Meyer Children's Hospital IRCCS | 2026-04-01 | 2026-10-26 | |
| Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease Rivaroxaban Oral Tablet [Xarelto], Aspirin or Clopidogrel, Warfarin - Kawasaki Disease, Coronary Artery Aneurysm | Phase 4 | Recruiting | Children's Hospital of Fudan University | 100 | 2025-06-01 | 2026-07-06 |
| Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease Rivaroxaban (Xarelto) - Kawasaki Disease, Pilot Study | Phase 4 | Recruiting | Children's Hospital of Fudan University | 10 | 2024-01-10 | 2026-10-22 |
| Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease Immunoglobulin G, Acetylsalicylic acid - Kawasaki Disease | Phase 4 | Completed | Green Cross Corporation | 45 | 2019-02-01 | 2020-05-21 |
| Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease immunoglobulin G - Kawasaki Disease | Phase 4 | Completed | Green Cross Corporation | 45 | 2012-01-01 | 2012-09-20 |
Cardiovascular Diseases (5) · Hemic and Lymphatic Diseases (5) · Lymphatic Diseases (5) · Skin Diseases (5) · Skin Diseases, Vascular (5) · Skin and Connective Tissue Diseases (5) · Vascular Diseases (5) · Vasculitis (5) · Aneurysm (2) · Coronary Disease (2) · Heart Diseases (2) · Myocardial Ischemia (2)
Aspirin (2) · Immunoglobulin G (2) · Rivaroxaban (2) · Clopidogrel (1) · Immunoglobulins, Intravenous (1) · Interleukin 1 Receptor Antagonist Protein (1) · Warfarin (1) · acarboxyprothrombin (1)
Children's Hospital of Fudan University (2) · Green Cross Corporation (2) · Meyer Children's Hospital IRCCS (1)
China (2) · South Korea (2)
Fang Liu, MD (2) · Gabriele Simonini, Prof (1) · June Huh, MD,Ph.D (1) · Mi Young Han, MD, Ph.D. (1)